No oxytocin benefit for autism

The so-called trust hormone, oxytocin, may not improve the symptoms of children with autism, a large study led by UNSW researchers has found.

Professor Mark Dadds, of the UNSW School of Psychology, says previous research suggested that – a hormone with powerful effects on linked to the formation of – could have benefits for children with the disorder.

"Many parents of children with autism are already obtaining and using oxytocin with their child, and clinical trials of the spray's effects are underway all over the world. Oxytocin has been touted as a possible new treatment, but its effects may be limited," Professor Dadds says.

Autism is a complex condition of unknown cause in which children exhibit reduced interest in other people, impaired and repetitive behaviours.

To determine its suitability as a general treatment Professor Dadds' team conducted a randomised controlled clinical trial of 38 boys aged between seven and 16 years of age with autism. Half were given a nasal spray of oxytocin on four consecutive days.

The study has been accepted for publication in the Journal of Autism and Developmental Disorders.

"We found that, compared to a placebo, oxytocin did not significantly improve , social interaction skills, repetitive behaviours, or general behavioural adjustment," says Professor Dadds.

"This is in contrast to a handful of previous smaller studies which have shown some positive effects on repetitive behaviours, and emotion processing.

"These studies, however, were limited by having small numbers of participants and/or by looking at the effects of single doses of oxytocin on specific behaviours or cognitive effects while the participants had the oxytocin in their system.

"The results of our much larger study suggest caution should be exercised in recommending nasal oxytocin as a general treatment for young people with autism."

The boys in the new study were assessed twice before treatment, three times during the treatment week, immediately afterwards and three months later, with a parent present. Factors such as eye contact with the parent, responsiveness, warmth, speech, positive body language, repetitive behaviours, and recognition of facial emotions were observed.

Research in people who are healthy shows oxytocin can increase levels of trust and eye-gazing and improve their identification of emotions in others.

One likely possibility is that many children with autism have impaired oxytocin receptor systems that do not respond properly, Professor Dadds says. But there may be a subgroup of children for whom oxytocin could be beneficial, and research is needed to determine who responds to it and how best to deliver it.

The team includes researchers from UNSW, the University of Melbourne and Neuroscience Research Australia. The study received funding from the National Health and Medical Research Council and was carried out at the Royal Far West facility.

Related Stories

Oxytocin improves brain function in children with autism

May 21, 2012

(Medical Xpress) -- Preliminary results from an ongoing, large-scale study by Yale School of Medicine researchers shows that oxytocin — a naturally occurring substance produced in the brain and throughout ...

Could nasal spray of 'love hormone' treat autism?

May 16, 2012

(HealthDay) -- Children with autism given a squirt of a nasal spray containing the hormone oxytocin showed more activity in brain regions known to be involved with processing social information, a small study ...

Recommended for you

Early warning sign for babies at risk of autism

Jul 24, 2014

Some babies are at risk for autism because they have an older sibling that has the disorder. To find new ways to detect Autism Spectrum Disorder (ASD) earlier in life, researchers are exploring the subtleties of babies' interactions ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Sinister1811
1 / 5 (3) Jul 19, 2013
I'm sure it did show a benefit. Like everything, they just didn't test it properly. What's the bet that they'll stop all further trials and funding and cease manufacturing it now.